Cannadorf

Cannabis Plant for Medical Use.

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in February 2019, Cannadorf operates with 1–10 employees, focusing on the medical cannabis sector. The company is currently in the Pre-Funding stage, developing a platform technology for sterile plant tissue cultivation in bioreactors to produce high-quality cannabis extracts.

Business overview

Cannadorf is dedicated to advancing cannabis extraction by producing cannabinoids, terpenes, and flavonoids in a medically safe manner. The company's core technology involves cultivating sterile plant tissue in bioreactors to ensure commercial production of premium plant extracts or specific Active Pharmaceutical Ingredients (APIs). Cannadorf aims to supply pharmaceutical companies with high-quality, sterile extracts and APIs, serving the pharmaceuticals, nutraceuticals, and cosmeceuticals markets without using synthetic molecules.

Strategic signal

In June 2022, Cannadorf was featured in news regarding a new Israeli development: a device capable of preparing RSO oil at home in 20 minutes. This highlights the company's potential to innovate within the medical cannabis space, signaling a focus on accessibility and novel product development that could attract consumer interest and strategic partnerships.

Log in to access full profile

Company Intelligence Q&A

What is Cannadorf's primary focus?
Cannadorf is focused on revolutionizing cannabis extraction to produce cannabinoids, terpenes, and flavonoids in a medically safe manner, aiming to supply pharmaceutical companies with high-quality and sterile extracts or Active Pharmaceutical Ingredients (APIs).
When was Cannadorf founded?
Cannadorf was founded in February 2019.
What innovative technology is Cannadorf developing?
Cannadorf is actively developing a platform technology that involves cultivating sterile plant tissue in bioreactors for the commercial production of premium plant extracts or specific APIs.
Which markets does Cannadorf aim to serve?
Cannadorf aims to meet the diverse needs of the pharmaceuticals, nutraceuticals, and cosmeceuticals markets.
What was a notable news mention for Cannadorf?
In June 2022, Cannadorf was mentioned in news regarding a new Israeli development: a device that prepares RSO oil at home in 20 minutes, showcasing the company's innovative approach to cannabis product development.
Log in to access full profile